New thiazolopyrimidine as anticancer agents: Synthesis, biological evaluation, DNA binding, molecular modeling and ADMET study

2020 ◽  
Vol 30 (23) ◽  
pp. 127611
Author(s):  
Sara T. Al-Rashood ◽  
Shymaa S. Elshahawy ◽  
Asmaa M. El-Qaias ◽  
Dina S. El-Behedy ◽  
Alshaimaa A. Hassanin ◽  
...  
MedChemComm ◽  
2018 ◽  
Vol 9 (2) ◽  
pp. 316-327 ◽  
Author(s):  
Yang Ping Quan ◽  
Li Ping Cheng ◽  
Tian Chi Wang ◽  
Wan Pang ◽  
Fan Hong Wu ◽  
...  

Compound 13a, more effective than CA-4 against HepG2 cells and tubulin, and the proposed binding mode for 13a.


Chirality ◽  
2014 ◽  
Vol 27 (2) ◽  
pp. 177-188 ◽  
Author(s):  
Demet Taşdemir ◽  
Ayşegül Karaküçük-İyidoğan ◽  
Mustafa Ulaşli ◽  
Tuğba Taşkin-Tok ◽  
Emİne Elçİn Oruç-Emre ◽  
...  

2017 ◽  
Vol 43 (12) ◽  
pp. 6765-6786 ◽  
Author(s):  
Yousry A. Ammar ◽  
Eman A. Fayed ◽  
Ashraf H. Bayoumi ◽  
Rogy R. Ezz ◽  
Mansour S. Alsaid ◽  
...  

RSC Advances ◽  
2014 ◽  
Vol 4 (70) ◽  
pp. 37197-37207 ◽  
Author(s):  
Wei-Ming Zhang ◽  
Man Xing ◽  
Ting-Ting Zhao ◽  
Yu-Jia Ren ◽  
Xian-Hui Yang ◽  
...  

Compound 30e with potent EGFR and HER-2 inhibitory activity may be a potential anticancer agent.


2019 ◽  
Vol 88 ◽  
pp. 102917 ◽  
Author(s):  
Dina M. Omran ◽  
Mariam A. Ghaly ◽  
Shahenda M. El-Messery ◽  
Farid A. Badria ◽  
Ehab Abdel-Latif ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document